Recurrent respiratory papillomatosis - rapid response to systemic bevacizumab

C. Schliemann, C. Biermann, A. Hilbis, T. Kessler, J. Schmidt, K. Wiebe, K. M. Müller, T. K. Hoffmann, C. Werner, A. H. Groll, C. Kessler, R. Wiewrodt, C. Rudack, B. Wolfgang, M. Mohr (Muenster, Ulm, Germany)

Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Session: Clinical management of orphan lung diseases
Session type: Oral Presentation
Number: 1798

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Schliemann, C. Biermann, A. Hilbis, T. Kessler, J. Schmidt, K. Wiebe, K. M. Müller, T. K. Hoffmann, C. Werner, A. H. Groll, C. Kessler, R. Wiewrodt, C. Rudack, B. Wolfgang, M. Mohr (Muenster, Ulm, Germany). Recurrent respiratory papillomatosis - rapid response to systemic bevacizumab. Eur Respir J 2013; 42: Suppl. 57, 1798

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014

Idiopathic plastic bronchitis and relapsing chylothorax
Source: International Congress 2016 – Orphan diseases II
Year: 2016


Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP)
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Clinicopathological features of the pulmonary aspergillosis with chronic interstitial pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014

Risk factors and treatment outcomes in patients with chronic pulmonary aspergillosis
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014

Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Viral infections
Year: 2013

Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia
Source: Eur Respir J 2013; 41: 402-409
Year: 2013



Mortality and survival predictor in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Sarcoidosis
Year: 2016

Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015

Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015

Interferon-γ therapy in two patients with progressive chronic pulmonary aspergillosis
Source: Eur Respir J 2006; 27: 1307-1310
Year: 2006



Pulmonary manifestations in severe strongyloidiasis: Review of 17 cases
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015

Chronic necrotizing aspergillosis, an emerging trend in clinical practice
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Predictors of exacerbations in patients with bronchiectasis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014